Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Multiple sclerosis

Vitamin D deficiency leads to excessive B-cell responses in multiple sclerosis

Vitamin D deficiency upregulates the immunoreactivity of B cells in patients with multiple sclerosis (MS), according to a new study. The finding supports the hypothesis that vitamin D supplementation could have a disease-modifying role in the management of MS.

Many studies have established that low levels of vitamin D are a risk factor for MS, but the exact nature of the effect is unclear. “Available data suggest that vitamin D in sufficient concentrations downregulates the activity of immune cells, in particular T lymphocytes,” explains Jürgen Haas, lead author of the new study. “The role of B cells in MS has been emphasized by the therapeutic efficiency of B-cell-depleting antibodies, but data on the interaction of vitamin D and B cells is scarce.”

Haas and colleagues studied this interaction in 95 patients with relapsing–remitting MS, almost half of whom had hypovitaminosis D — a serum level of the metabolite 25-hydroxyvitamin D (25(OH)D) below 20 ng/ml. They combined measurements of 25(OH)D in the blood and cerebrospinal fluid (CSF) of patients with in vitro cell-based experiments to assess the effects of vitamin D on B cell immunoreactivity.

“the effects of vitamin D deficiency on B cells exacerbate disease activity in MS”

B cells isolated from 28 patients with MS exhibited greater proliferation and release of IL-6 in response to immunostimulants than did B cells from healthy controls or individuals with other disorders, and immunoreactivity was particularly high in the cells from MS patients with hypovitaminosis D. Incubation of isolated B cells in different concentrations of the active metabolite of vitamin D demonstrated that the immunoreactivity of these cells was dependent on the dose of the metabolite.

MS patients with hypovitaminosis D had higher Expanded Disability Status Scale scores and more-frequent relapses than did MS patients with sufficient vitamin D, indicating more-severe disease. In 12 patients whose B-cell function was assessed before and after taking vitamin D supplements, the B-cell proliferative response and IL-6 release was decreased after supplementation.

Haas and co-workers also showed that hypovitaminosis D translates into CNS effects. “Patients with a low vitamin D status exhibited decreased vitamin D levels in the CSF and more-marked intrathecal enrichment of antigen-experienced, class-switched memory B cells and antibody-secreting plasma cells,” says Haas. “These data support the hypothesis that hypovitaminosis D in the blood and CSF act together to negatively interfere with immune responses outside and inside the CNS.”

The researchers conclude that the effects of vitamin D deficiency on B cells exacerbate disease activity in MS, indicating that ongoing trials of vitamin D supplementation are likely to demonstrate therapeutic effects.


  1. 1

    Haas, J. et al. Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis. J. Neuroimmunol., (2016)

Download references


Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fyfe, I. Vitamin D deficiency leads to excessive B-cell responses in multiple sclerosis. Nat Rev Neurol 12, 252 (2016).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing